Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 66Rectal Neoplasms 61Colorectal Neoplasms 56Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Neoplasm Metastasis 12Lymphoma 12Burkitt Lymphoma 11Leukemia 9Unspecified Adult Solid Tumor, Protocol Specific 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 6Carcinoma, Hepatocellular 6Stomach Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Pancreatic Neoplasms 5Gallbladder Neoplasms 5Bile Duct Neoplasms 5Acquired Immunodeficiency Syndrome 5Neoplasms 4HIV Infections 4Osteosarcoma 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Esophageal Neoplasms 3Sarcoma 2Ovarian Neoplasms 2Neoplasms, Unknown Primary 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Specimen Handling 2Nivolumab 2pembrolizumab 1avelumab 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Fluorouracil 1Diffusion Tensor Imaging 1Capecitabine 1CTLA-4 Antigen 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Turcot syndrome × Leucovorin × Clear all
NCT03050814 2021-12-20

Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
30 enrolled 15 charts
Gastrointestinal

Turcot syndrome, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡